Acute Lymphoblastic Leukemia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Conditions: Leukemia, Lymphoblastic Interventions: Dietary Supplement: enteral or parenteral nutritional support Sponsors: Central Hospital, Nancy, France Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials

Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After " Magic Massages "
Conditions: Acute Lymphoblastic Leukemia, Pediatric Interventions: Other: Self-report questionnaires (only for parents); Other: Interview (only for parents); Other: Clinical data collection (only concerning Children) Sponsors: Centre Leon Berard; Institut d ' H ématologie et d ' Oncologie P édiatrique; Fondation La Roche Posay Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Conditions: Lymphoblastic Leukemia in Children Interventions: Drug: induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate; Drug: Consolidation: Vincristine, Mecaptopurine, Intrathecal Methotrexate; Drug: Consolidation: Vincristine, Mecaptopurine, Cyclophosphamide, Cytarabine, L-asparaginase, Intrathecal Methotrexate; Drug: Interim Maintenance(IM): Vincristine, Methotrexate, Intrathecal Methotrexate; Drug: Interim Maintenance(IM): Vincristine, Methotrexate, Mercaptopurine, Intrathecal Methotrexate; Drug: Delayed Intesification(DI): Vincristine, Mercaptopurine, L-asparaginase, Dox...
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD
Conditions: Acute Lymphoblastic Leukemia; Hodgkin Disease; Allogeneic Stem Cell Transplantation Interventions: Diagnostic Test: Low-field magnetic resonance imaging; Diagnostic Test: Cardiopulmonary testing; Diagnostic Test: Pulmonary testing; Diagnostic Test: Blood sample Sponsors: University of Erlangen-N ürnberg Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials

A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients
Conditions: Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Interventions: Drug: chidamide; Drug: Venetoclax Oral Tablet; Drug: Inotuzumab Ozogamicin Sponsors: Institute of Hematology& Blood Diseases Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia
Conditions: B-cell Acute Lymphoblastic Leukemia; B-cell Lymphoma; Diffuse Large B Cell Lymphoma Interventions: Drug: CD19/CD22-bispecific CAR-T cells Sponsors: Beijing Tongren Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials

Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-na ïve Ph+ Acute Lymphoblastic Leukemia
Conditions: Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Interventions: Drug: Olverembatinib plus venetoclax and dexamethasone Sponsors: Xijing Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials

Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL
Conditions: B-cell Acute Lymphoblastic Leukemia Interventions: Drug: CD19-CAR_Lenti_ALLO Sponsors: Bambino Ges ù Hospital and Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

CD19CD22 CAR-T Therapy in Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia
Conditions: B Acute Lymphoblastic Leukemia; Ph-Negative ALL; High Risk Acute Lymphoblastic Leukemia Interventions: Drug: Azacitidine Injection; Drug: Venetoclax; Drug: CD19CD22 CAR-T Sponsors: The First Affiliated Hospital of Soochow University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials

CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).
Conditions: B Acute Lymphoblastic Leukemia; Ph-Negative ALL; High Risk Acute Lymphoblastic Leukemia Interventions: Drug: Azacitidine Injection; Drug: Venetoclax; Drug: CD19CD22 CAR-T Sponsors: The First Affiliated Hospital of Soochow University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
Conditions: Acute Lymphoblastic Leukemia, Pediatric Interventions: Behavioral: CareMeds Intervention Sponsors: Roswell Park Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials

CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL
Conditions: T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Interventions: Biological: CD7-CART01 Sponsors: Bambino Ges ù Hospital and Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials

Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
Conditions: Burkitt Lymphoma; Lymphoblastic Lymphoma, Adult; Acute Lymphoblastic Leukemia, Adult Interventions: Drug: Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Conditions: Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Interventions: Drug: Imatinib; Drug: Ponatinib; Drug: Blinatumomab; Other: Indication for stem cell transplantation Sponsors: Goethe University; Deutsche Leuk ämie-& Lymphom-Hilfe; German Federal Ministry of Education and Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myeloid Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid System Neoplasm; Hodgkin Lymphoma; Myelodysplastic Syndrome; Myelofibrosis; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation; Procedure: Biospecimen Collection; Drug: Granulocyte Colony-Stimulating Factor; Drug: Hematopoietic Cell Transplantation Conditioning Regimen; Biological: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine; Procedure: Pheresis; Drug: Placebo Administration; ...
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials